Polyaspartate; polyaspartate polymers; crosslinked polyaspartate; water swellable polymers; superabsorbent polymers; viscosity modifying polymers; polyaspartate polymeric additives; polyaspartate for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymers for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymeric additives for use in the manufacture of industrial, consumer, agricultural, and household products; crosslinked polyaspartate for use in the manufacture of industrial, consumer, agricultural, and household products; water swellable polymers for use in the manufacture of industrial, consumer, agricultural, and household products; superabsorbent polymers for use in the manufacture of industrial, consumer, agricultural, and household products; viscosity modifying polymers for use in the manufacture of industrial, consumer, agricultural, and household products.

Shampoings; dentifrices; bains de bouche; nettoyants pour le visage; démaquillants; savons; savons pour soin corporel; produits lavants ou déodorants pour la toilette intime.

Gratte-langue.

The operation of a program that assists buyers in acquiring a residential dwelling

Sale of residential, commercial and industrial real estate projects and developments; financing, lending and mortgage services for residential homes, commercial and industrial buildings; rental and leasing services for residential homes, commercial and industrial buildings; real estate brokerage and agency services; real estate management; consulting and advisory services in relation to real estate and real estate development and management; the operation of a business building, selling or renting residential dwellings and commercial and industrial buildings

Downloadable and recorded network management software for routers, switches, wireless devices, and wireless access point devices; downloadable and recorded network management computer operating software programs for routers, switches, wireless devices, and wireless access point devices; downloadable and recorded computer software for use in connecting local area networks, public networks, cloud networks, and hybrid networks and systems, servers and storage devices; computer network switches, servers, routers, and wireless access point devices; downloadable and recorded computer software for network security, monitoring network traffic and access, optimizing network performance, performing network diagnostics, detecting malware and network threats, and reporting network security and performance analytics.

Software as a service (SAAS) services featuring software for interconnecting computers, computer networks, cloud networks, wireless access points, servers and storage devices; software as a service (SAAS) services featuring software for use in controlling the operation and management of local area networks, public networks, cloud networks, and hybrid networks; software as a service (SAAS) services featuring software for network security, monitoring network traffic and access, optimizing network performance, performing network diagnostics, detecting malware and network threats, and reporting network security and performance analytics; platform as a service (PAAS) services featuring cloud networking software for routers, switches, wireless devices, and wireless access point devices.

Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, bipolar disorder, depressive disorders, psychosis, irritability associated with autistic disorder, and reward disorders, namely eating disorders; Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Parkinson's disease and amyotrophic lateral sclerosis (ALS); Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely diabetes, dyslipidemia and obesity

Hemostats; absorbable hemostatic particles used to accelerate the clotting of blood, parts and fittings therefor; medical and surgical dressings, namely, topical hemostatic dressings for the treatment of wounds, namely, minor cuts, lacerations, abrasions, severely bleeding wounds, puncture wounds, surgical wounds, skin grafts and burns; hemostatic powder spray applicator and fittings therefor for the treatment of wounds, namely, minor cuts, lacerations, abrasions, severely bleeding wounds, puncture wounds, surgical wounds, skin grafts and burns

Medical and surgical dressings, namely, topical hemostatic dressings for the treatment of wounds, namely, minor cuts, lacerations, abrasions, severely bleeding wounds, puncture wounds, surgical wounds, skin grafts and burns; hemostatic powder spray applicator and fittings therefor for the treatment of wounds, namely, minor cuts, lacerations, abrasions, severely bleeding wounds, puncture wounds, surgical wounds, skin grafts and burns; absorbable hemostat for control of profuse bleeding

Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases.

Metal waste and recycling containers for indoor and outdoor commercial use.

Non-metal waste and recycling containers for indoor and outdoor commercial use.

Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders namely mild to moderate to severe depressive episodes, anxiety disorders, psychosis, irritability associated with autistic disorder, schizoaffective disorder, treatment of Tourette's disorder, agitation associated with schizophrenia and bipolar mania, acute treatment of manic and mixed episodes associated with Bipolar I disorder, and reward disorders, namely eating disorders; pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS); pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely, diabetes, dyslipidemia and obesity; pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders namely mild to moderate to severe depressive episodes, anxiety disorders, psychosis, irritability associated with autistic disorder, schizoaffective disorder, treatment of Tourette's disorder, agitation associated with schizophrenia and bipolar mania, acute treatment of manic and mixed episodes associated with Bipolar I disorder, and reward disorders, namely eating disorders

Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders namely mild to moderate to severe depressive episodes, anxiety disorders, psychosis, irritability associated with autistic disorder, schizoaffective disorder, treatment of Tourette's disorder, agitation associated with schizophrenia and bipolar mania, acute treatment of manic and mixed episodes associated with Bipolar I disorder, and reward disorders, namely eating disorders; pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of neurodegenerative diseases, namely Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS); pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of cardiovascular diseases; pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of metabolic diseases, namely, diabetes, dyslipidemia and obesity; pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, namely psychiatric disorders, namely schizophrenia, clinical depression, major depressive disorder, bipolar disorder, anxiety and panic disorders, substance abuse and dependence, depressive disorders namely mild to moderate to severe depressive episodes, anxiety disorders, psychosis, irritability associated with autistic disorder, schizoaffective disorder, treatment of Tourette's disorder, agitation associated with schizophrenia and bipolar mania, acute treatment of manic and mixed episodes associated with Bipolar I disorder, and reward disorders, namely eating disorders